6 03, 2025 Shooting Cancer Highlights – Periodic focus on regulatory status of new targeted therapies in oncology adlitterio663392025-03-06T10:14:19+01:00 Mehr erfahren
10 01, 2025 Shooting Cancer Highlights – Periodic focus on regulatory status of new targeted therapies in oncology adlitterio663392025-01-10T15:00:06+01:00 Mehr erfahren
13 11, 2024 Shooting Cancer Highlights – Periodic focus on regulatory status of new targeted therapies in oncology adlitterio663392024-11-13T14:07:16+01:00 Mehr erfahren
11 07, 2024 Shooting Cancer Highlights – Periodic Focus on regulatory status of new targeted therapies in oncology adlitterio663392024-07-11T14:10:47+02:00 Mehr erfahren
13 03, 2024 Shooting Cancer Highlights – Periodic focus on regulatory status of new targeted therapies in oncology adlitterio663392024-03-13T09:56:28+01:00 Mehr erfahren
21 12, 2023 Shooting Cancer Highlights – Monthly focus on regulatory status of new targeted therapies in oncology – November 2023 adlitterio663392023-12-21T10:08:16+01:00 Mehr erfahren
6 11, 2023 Shooting Cancer- Highlights Monthly focus on regulatory status of new targeted therapies in oncology – September and October 2023 adlitterio663392023-11-07T14:50:33+01:00 Mehr erfahren
6 11, 2023 Shooting Cancer Highlights – Monthly focus on regulatory status of new targeted therapies in oncology – September and October 2023 adlitterio663392024-07-11T14:13:29+02:00 Mehr erfahren
28 06, 2023 Shooting Cancer- Highlights Monthly focus on regulatory status of new targeted therapies in oncology – April and May 2023 adlitterio663392023-06-28T10:28:18+02:00 Mehr erfahren
28 06, 2023 Shooting Cancer Highlights – Monthly focus on regulatory status of new targeted therapies in oncology – April and May 2023 adlitterio663392023-06-28T10:22:08+02:00 Mehr erfahren
